Brief: Eagle Pharmaceuticals Q1 revenue USD 66.3 million
09/05/2023 13:59
May 9 (Reuters) - Eagle Pharmaceuticals Q1 net income USD 5.8 million. * Q1 revenue USD 66.3 million * Q1 adjusted net income USD 16.5 million * Outlook FY adjusted EBITDA USD 74-80 million * Outlook FY adjusted EPS USD 4.2-4.53
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq